A G Harris Selected Research

Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)

1/2019

Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A G Harris Research Topics

Disease

2	Osteoporosis 01/2019 - 01/2018
2	Seasonal Allergic Rhinitis (Hay Fever) 06/2003 - 06/2000
1	Osteoporotic Fractures 01/2019
1	Postmenopausal Osteoporosis 01/2019
1	Epidermolysis Bullosa 04/2017
1	Allergic Rhinitis 01/2005
1	Chronic Urticaria 01/2005
1	Neoplasm Metastasis (Metastasis) 05/2002
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2000
1	Ischemia 07/2000
1	Phototoxic Dermatitis (Phototoxicity) 07/2000
1	Stable Angina 07/2000
1	Infections 05/2000

Drug/Important Bio-Agent (IBA)

2	Teriparatide (Parathar)FDA Link 01/2019 - 01/2018
2	abaloparatideIBA 01/2019 - 01/2018
2	desloratadine (Aerius)FDA LinkGeneric 01/2005 - 06/2003
2	Histamine Antagonists (Antihistamines)IBA 06/2003 - 06/2000
1	Peptides (Polypeptides)IBA 01/2019
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 01/2019
1	AcidsIBA 01/2019
1	Semaxinib (SU5416)IBA 05/2002
1	fluorescein isothiocyanate dextranIBA 07/2000
1	NitratesIBA 07/2000
1	Loratadine (Alavert)FDA Link 06/2000
1	fexofenadine (Allegra)FDA LinkGeneric 06/2000
1	Amoxicillin (Wymox)FDA LinkGeneric 05/2000

Therapy/Procedure

1	Therapeutics 04/2017